Sleep Apnea Screening

Sponsor
Arrhythmia Network Technology S.L. (Other)
Overall Status
Terminated
CT.gov ID
NCT02569749
Collaborator
(none)
15
9
1.7

Study Details

Study Description

Brief Summary

To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.

Condition or Disease Intervention/Treatment Phase
  • Other: Berlin and Epworth questionaries
  • Other: Sleep apnea monitoring in those patients in whom a pacemaker with monitoring apnea system has been implanted.
  • Other: Night polygraph / Polysomnography

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
15 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Sleep Apnea-Hypopnea Syndrome Screening
Study Start Date :
Jun 1, 2015
Anticipated Primary Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Group 1

Patients with pacemaker indication (pacemaker already implanted or to be implanted)

Other: Berlin and Epworth questionaries

Other: Sleep apnea monitoring in those patients in whom a pacemaker with monitoring apnea system has been implanted.

Other: Night polygraph / Polysomnography

Group 2

Patients with ICD or CRTD therapy indication (device already implanted or to be implanted)

Other: Berlin and Epworth questionaries

Other: Night polygraph / Polysomnography

Group 3

Patients with heart failure an preserved LVEF (40-50%)

Other: Berlin and Epworth questionaries

Other: Night polygraph / Polysomnography

Group 4

Patients with heart failure and reduced LVEF (<40%)

Other: Berlin and Epworth questionaries

Other: Night polygraph / Polysomnography

Outcome Measures

Primary Outcome Measures

  1. Percentage of patients with SAHS in patients with pacemaker indication [1 month]

  2. Percentage of patients with SAHS in patients with ICD or CRTD therapy [1 month]

  3. Percentage of patients with SAHS in patients with heart failure and preserved LVEF [1 month]

  4. Percentage of patients with SAHS in patients with reduced LVEF [1 month]

Secondary Outcome Measures

  1. Percentage of patients with obstructive sleep apnea in all groups [1 month]

  2. Percentage of patients with central sleep apnea in all groups [1 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 years or older

  • No previous diagnosis of sleep apnea

  • Fulfilling at least one of the following:

  1. Pacemaker indication

  2. ICD or CRTD therapy indication

  3. Heart failure and preserved LVEF (40-50%)

  4. Heart failure and reduced LVEF (<40%)

  • Signed informed consent
Exclusion Criteria:
  • Age younger than 18 years

  • Renal hemodialysis

  • Cardiac transplant indication

  • Women who are pregnant

  • Advanced cancer

  • Enrollment in another investigational study

  • Able and willing to comply with all testing and requirements

  • Patient not suitable for inclusion due to psychiatric conditions or short life expectancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Infanta Cristina Badajoz Spain
2 Hospital Universitario de Burgos Burgos Spain
3 Hospital General Universitario de Ciudad Real Ciudad Real Spain
4 HM Hospitales Madrid Spain
5 Hospital Clínico Universitario San Carlos Madrid Spain
6 Hospital Universitario de Fuenlabrada Madrid Spain
7 Hospital Universitario La Paz Madrid Spain
8 Hospital Universitario Puerta de Hierro Madrid Spain
9 Hospital Nuestra Señora de Sonsoles Ávila Spain

Sponsors and Collaborators

  • Arrhythmia Network Technology S.L.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Arrhythmia Network Technology S.L.
ClinicalTrials.gov Identifier:
NCT02569749
Other Study ID Numbers:
  • SAHS2
First Posted:
Oct 7, 2015
Last Update Posted:
Nov 3, 2015
Last Verified:
Nov 1, 2015

Study Results

No Results Posted as of Nov 3, 2015